The Mouse and Tissue Core (Core B) is designed to enhance the scientific objectives and cost-effectiveness of the Program Project in the following ways: 1) by serving as a central facility for the breeding and maintenance of mouse models of diabetes and atherosclerosis utilized by program project investigators, 2) by participating in the planning and implementation of longitudinal studies of these murine models, 3) by serving as a central facility for the collection and processing (freezing and/or fixation and paraffin embedding) of tissues and cells from these murine models, 4) by providing investigators with expertise in pathology-based analytical techniques such as histological staining, immunohistochemistry, immunofluorescence microscopy and in situ hybridization, most of which will be performed in this Core unit, and 5) by quantifying and characterizing atherosclerotic lesions and providing morphological characterization of other tissues taken from murine models used by program project investigators. Centralizing and standardizing planning, breeding and maintenance of mice for animal experiments, as well as tissue collection and methods of analyses in a single, integrated Core will increase the likelihood of obtaining reliable results and not compel individual Projects to perform duplicative animal experiments or to develop technical expertise in these areas. Further, carrying out these studies in a single, integrated Core will allow the results to be made available to each project in a way that facilitates Project interactions.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL092969-52
Application #
8375977
Study Section
Special Emphasis Panel (ZHL1-PPG-J)
Project Start
Project End
2014-05-31
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
52
Fiscal Year
2012
Total Cost
$260,895
Indirect Cost
$103,853
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Scolaro, Bianca; Nogueira, Marina S; Paiva, Aline et al. (2018) Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine. Mol Metab 11:137-144
Fang, Xiang; Dorcely, Brenda; Ding, Xi-Ping et al. (2018) Glycemic reduction alters white blood cell counts and inflammatory gene expression in diabetes. J Diabetes Complications 32:1027-1034
Wight, Thomas N (2018) A role for proteoglycans in vascular disease. Matrix Biol 71-72:396-420
Bornfeldt, Karin E; Kramer, Farah; Batorsky, Anna et al. (2018) A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis. Am J Pathol 188:343-352
Basu, Debapriya; Huggins, Lesley-Ann; Scerbo, Diego et al. (2018) Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition. Arterioscler Thromb Vasc Biol 38:2207-2216
Subramanian, Savitha; Goodspeed, Leela; Wang, Shari et al. (2018) Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr-/- Mice. Int J Mol Sci 19:
Goldberg, Ira J; Reue, Karen; Abumrad, Nada A et al. (2018) Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop. Circulation 138:305-315
He, Yi; Kothari, Vishal; Bornfeldt, Karin E (2018) High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus. Arterioscler Thromb Vasc Biol 38:e10-e16
Pourmousa, Mohsen; Song, Hyun D; He, Yi et al. (2018) Tertiary structure of apolipoprotein A-I in nascent high-density lipoproteins. Proc Natl Acad Sci U S A 115:5163-5168
Kim, KyeongJin; Goldberg, Ira J; Graham, Mark J et al. (2018) ?-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL Receptor. Cell Metab 27:816-827.e4

Showing the most recent 10 out of 136 publications